FDA Adverse Event Injury Summary report: N

S-ROM*SLEEVE PRX ZTT, 20D-SML

MDR report key: 9617626 · Received January 22, 2020

Report

Report Number
1818910-2020-02512
Event Type
Injury
Date Received
January 22, 2020
Report Date
January 8, 2020
Manufacturer
DEPUY ORTHOPAEDICS INC US
Product Code
LPH
UDI-DI
10603295175339
PMA / PMN Number
K934412
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # (B)(4). INVESTIGATION SUMMARY ==> NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. THE INFORMATION RECEIVED WILL BE RETAINED FOR POTENTIAL SERIES INVESTIGATIONS IF TRIGGERED BY TREND ANALYSIS, POST MARKET SURVEILLANCE, OR OTHER EVENTS WITHIN THE QUALITY SYSTEM. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED, AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. DEVICE HISTORY LOT ==> 2153493. (B)(4). DEVICE HISTORY REVIEW ==> REVIEW OF THE DEVICE MANUFACTURING RECORDS FOUND NO RELATED DEVIATIONS OR ANOMALIES. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4). INITIAL REPORTER OCCUPATION: LAWYER. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

PFS AND MEDICAL RECORDS RECEIVED. PFS ALLEGED NUMBNESS IN LEGS AND FEET AFTER FIRST REVISION. ADDED CUP, APEX HOLE ELIMINATOR AND SLEEVE TO CAPTURE THE ALLEGATION. DOI: (B)(6) 2017 (LINER & HEAD); DOI: (B)(6) 2009 (CUP, APEX & SLEEVE); DOR: NONE REPORTED RIGHT HIP. PLEASE SEE (B)(4) RIGHT HIP 1ST REVISION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
78456 S-ROM*SLEEVE PRX ZTT, 20D-SML S-ROM HIP SYSTEM : HIP FEMORAL SLEEVE LPH DEPUY ORTHOPAEDICS INC US 55-0533 2153493 10603295175339

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention